Back to search

Article

Corrected: A Prognostic Necroptosis-Related lncRNA Signature to Predict the Immune Response and Drug Sensitivity of Bladder Cancer

2022-04-07

Abstract excerpt

<h4>Background: </h4> Patients with bladder cancer (BLCA), especially those with advanced stage cancer, have a short life span; thus, new drugs need to be developed urgently to improve the situation. Long noncoding RNAs (lncRNAs) are considered regulatory targets for cancer, including BLCA. Therefore, we constructed a promising signature of lncRNAs related to necroptosis and further predicted the immune response a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
514ae00d-86a3-5134-9c5d-242d9a54e1ea
DOI
10.21203/rs.3.rs-1530906/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Corrected: A Prognostic Necroptosis-Related lncRNA Signature to Predict the Immune Response and Drug Sensitivity of Bladder CancerDOI 10.21203/rs.3.rs-1530906/v1
Select a neighboring publication to make it the new centre.